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Introduction: 
The thought process that respiratory 
depression, also known as hypoventilation, 
should of detected before the incidence of 
apnea has yet to considered necessary. 
The current standard of care is similar to the 
process used by fire alarms.  A fire is 
started, an alarm is sounded and the fire 
department arrives to put out the fire and 
minimize the damage.  Yet, damage still 
occurs.  The use of capnometry and pulse 
oximetry for the detection of hypoventilation 
performs in the same manner.  A patient is 
struggling to breath; s/he eventually stops 
breathing, the pulse oximeter continues to 
average the measurements and finally 
sounds an alarm.  The capnometer 
continues to register CO2 during the 
struggling breaths; eventually, it too sounds 
an alarm.  The nursing staff is attending 
another patient and comes as soon as 
possible.  90 seconds later the staff arrives 
and the patient has stopped breathing, 
developed abnormal cardiac rhythms, and is 
developing respiratory acidosis.  In the last 
couple of minutes the situation turned from 
one of prevention to one of crisis.  
Unfortunately the damage has been done 
and the nursing staff can only do their best 
to prevent further damage.   
Background: 
Two thirds of unexpected hospital deaths 
are attributed to hypoventilation [1].  After 
surgery, 0.5% to 5.2% of all patients receive 
analgesics to control pain [2,3,4].  When 
analgesics are given in concentrations high 
enough to control pain, the drugs depress 
the patient’s respiratory system.  This 
causes the patient’s respiratory rate (RR) to 
fall and the tidal volume (TV) of each breath 
decreases.  As the TV decreases, each 
breath becomes inadequate to inhale 
sufficient oxygen.  Supplemental oxygen is 
frequently delivered to patients post-
anesthetic surgery.  It is necessary to 
maintain adequate SpO2 concentrations. 
If supplemental oxygen is not successfully 
delivered to these patients, hypoxemia and 
or death may occur.  Deaths caused by 
respiratory depression are preventable if 
detection is provided early on and 
supplemental oxygen is delivered correctly. 
Apnea occurs in different forms.  Central 
apnea occurs when the patient makes little 
to no effort to breath.  It is often caused as 
an effect of receiving too much of an opioid 
agent.  Obstructive apnea occurs when the 
airway tissues are relaxed that they block 
the flow of gas, and thereby, reduce the 
volume of air that patient receives.  
Obstructive apnea occurs frequently during 
sedation by receiving too much of a 
sedative agent. 
The current standard of care to monitor 
respiration is provided by either pulse 
oximetry or capnography [5].  Pulse 
oximetry measure the SpO2 (saturation of 
peripheral oxygen) in the patient’s arterial 
blood.  Pulse Oximeters continually average 
the SpO2 and therefore are slow to respond 
to apnea.  Furthermore when a patient’s 
respiration is depressed and supplemental 
oxygen is being delivered, the O2 
concentration in his/her lungs remain 
relatively normal.  Yet, during this period of 
hypoventilation the concentration of carbon 
dioxide (CO2) in the patient’s arterial blood 
rises (hypercarbia), and the patient 
becomes increasingly susceptible to 
abnormal cardiac rhythms.  This can directly 
lead to cardiac arrest and or death.  These 
patients become hypercarbic long before 
the pulse oximeter alarms [6,7,8].   
Capnometry also has limitations that make it 
unsuitable for the detection of respiratory 
depression.  Capnometers are unreliable 
when used with patients that are breathing 
spontaneously and when receiving 
supplemental O2 [9,10].  The O2 dilutes the 
expired CO2 sample and therefore interferes 
with the measurement.  Capnometry’s 
sensitivity for the detection of apnea in non-
intubated patients is 62%.  This is low and 
due to this, capnometers miss more events 
of apnea than is tolerable for adequate 
patient care [11].  Finally, capnometers 
require a complex gas sampling system and 
infrared gas analyzer.  This makes them 
more complex and expensive than a system 
based from a pressure transducer. 
 Significance: 
Using a pressure signal to detect 
hypoventilation and apnea was first 
described by Guyatt et al. [12].  A pressure 
transduced connected to a nasal oxygen 
cannula is capable of detecting pressure 
fluctuations of approximately 1 cm H2O 
during breathing.  The cannula uses the 
nasal prongs as pitot tubes.  A square root 
transformation of the original pressure 
signal gives a linear relationship when 
compared to airflow.  Measurements of 
pressure are accurate at high ventilation 
rates when supplemental oxygen was also 
given through the cannula 
[13,14,15,16,17,18].  Ballester et al. found 
that using nasal pressure has a respiratory 
detection rate of 96.8% [19].   
Measuring respiratory pressure is the 
preferred method for the diagnosing of 
obstructive sleep apnea.  However, this 
requires the nasal cannula to be accurately 
positioned at all times.  Currently this is 
difficult for the medical staff to determine.  
Nasal cannula prongs frequently dislodge 
from their ideal location within the nares of 
the nose.  Without the constant assistance 
of a nurse to reposition the cannula, the 
system would cause too many false alarms.  
This would only increase to the constant 
“alarm fatigue” that is experienced by all 
medical staffs.  Therefore, we propose to 
develop a method to determine the position 
of the nasal prongs by analyzing the 
pressure changes caused by oxygen flow 
during respiration.  This would provide the 
ability to identify a misplaced or dislodged 
cannula.  This will increase the 
effectiveness of delivered supplemental 
oxygen and improve upon the current 
methods to monitor respiratory depression 
post-surgery. 
Innovation: 
New pressure transducer technology 
provides the ability to increase the accuracy 
of flow measurements. Using these 
measurements the pressure apnea monitor 
can detect when the cannula is 
inadequately positioned or dislodged.  This 
is possible by measuring both the 
supplemental O2 flow rate and inside of the 
nasal cavity.  Using both we can calculate a 
relationship between the backpressure 
within the nasal cavity as the O2 fills it and 
the placement of the cannula.  Thereby, 
providing a factor to determine when the 
cannula is misplaced. 
This new development also enables us to 
detect airway obstructive and central 
respiratory depression.  With obstructive 
respiratory depression the backpressure 
measured within the nasal cavity will 
fluctuate and contain higher frequency 
components during partial obstruction and 
subsequent snoring.  Central respiratory 
depression will be identified by observing 
small and infrequent pressure swings that 
occur when the breath rate is slow and or 
the tidal volumes are small. 
Additionally, this new technology provides 
for enhanced accuracy and efficiency in 
detecting pressure measurements.  Our 
pressure transducer will use a second 
compensating solid-state diaphragm that 
automatically adjusts for the effects of 
gravity and temperature.  This provides a 
system that is less affected by positional 
changes and temperature drift.  We will 
process the pressure signal with a precision 
adjustable gain differential amplifier and a 
high-resolution analog to digital converter 
system to allow for precise and accurate 
measurements at very low pressures.  
Preliminary Studies: 
Figure 1 is a block diagram of the current 
prototype.  It includes a traditional oxygen 
flow meter (Figure 2) and an inexpensive 
differential pressure sensor (MPXV5004DP, 
FreeScale Seminconductor, Austin TX).  
Both are connected to a divided nasal 
cannula (Figure 3).    
The nasal cannula was placed on a 
mannequin that simulates an adult nasal 
cavity, oral cavity, larynx, and trachea.   The 
simulated trachea was connected to a 
mechanical test lung (Figure 6).  Preliminary 
data (Figure 4) shows the pressure 
measured in the right prong of the nasal 
	  
Figure 1: Block diagram of the pressure signal apnea monitor prototype. 
	  
Figure 2: Drawing of a traditional oxygen flow meter. 
cannula.  The lower plot shows the airway 
flow measured during inspiration and 
expiration by a research spirometer 
(RSS100 Korr Medical Technologies, Salt 
Lake City, UT). 
Research Design: 
Our research plan is to first, build a working 
prototype.  Second, measure the device’s 
performance using a simulated patient in 
order to identify the optimum pressure 
thresholds for the detection of a dislocated 
nasal cannula and the enunciation of alarms 
for inadequate tidal volume and respiratory 
rate.  Third, to conduct clinical trails to test 
the feasibility of using our device during 
operative procedures. 
Methods: 
Aim 1: Build a working prototype: 
Figure 5 demonstrates a future iteration of 
the prototype.  Our device will connect 
	  
Figure 3: Drawing of the EtCO2 divided sampling 
cannula with simultaneous oxygen delivery (Salter 
Labs, Arvin, CA).  Instead of sampling CO2 from the 
right nasal prong, we will measure nasal pressure.   
	  
	  
Figure 4: Top: Pressure measured in the right nasal prong of the cannula with 5 L/min of O2 was delivered 
through the left prong.  Bottom: Simulated airflow rate measured in the trachea during three spontaneous 
breaths.  
directly to a hospital oxygen connector at 
approximately 55 PSI.  Due to the fact that 
built in wall pressure is much higher than 
the pressure at which supplemental oxygen 
is delivered to the patient, a precisions flow 
resistor is necessary to decrease the 
pressure to a suitable 5 PSI.  We will use a 
differential pressure transducer 
(MPXV5004DP, FreeScale Semiconductor, 
Austin TX) to measure the pressure drop as 
the oxygen flows through the resistor.  A 
microcontroller will convert the pressure 
drop to a flow rate. 
Software algorithms will be developed that 
use the oxygen flow rate to identify when a 
cannula is dislodged.  Supplemental oxygen 
is delivered through the left nasal prong of 
the nasal cannula (Figure 3).  As oxygen 
fills the patient’s nasal cavity, the pressure 
within the cavity increases proportionally to 
the oxygen flow rate.  Since we can 
accurately calculate the oxygen flow rate 
from the wall connector, we can calculate 
the anticipated nasal cavity backpressure 
when the nasal prongs are correctly 
positioned within the patient’s nares.  
Should either a single nasal prong or both 
nasal prongs become dislodged, the nasal 
backpressure will be abnormally low.  
During the simulation testing we will 
determine the baseline pressure threshold 
that is accurately identify a displaced 
cannula.  Furthermore when a cannula is 
detected as dislodged, the device will sound 
an alarm and display a text message to alert 
the medical staff.  This will provide 
adequate warning before incidences of 
apnea or other hypoventilation occurrences.   
The pressure signal apnea monitor will 
measure the nasal pressure through the 
right prong of the nasal cannula (Figure 3).  
This is directly connected to the pressure 
port connector shown in Figure 5.  The 
internal pressure transducer (BLVR-L01D, 
AllSensors, Morgan Hill, CA) includes a 
second compensating solid-state diaphragm 
that adjusts automatically for the effects of 
gravity and temperature.  This helps to 
prevent positional changes and temperature 
drift.  The pressure signal will be processed 
using a precision adjustable gain scale 
differential amplifier and a high-resolution 
analog to digital converter system.  This is 
necessary due to the small measurements 
on the order of 0.001 cm H2O.   
Additional software algorithms will be 
developed to use the measured pressure 
signal to calculate the patient’s expired tidal 
volume and respiratory rate.  These 
algorithms will provide thresholds that were 
determined during the simulation testing 
adequate tidal volumes and respiratory 
rates.  We expect that our device will have a 
detection rate of 97%, as reported by the 
literature [19].  The device’s alarms will 
provide user feedback when the tidal 
volume is less that 150 ml or when the 
respiratory rate is below 4 b/min.  These 
notification alarms will improve the patient 
	  
Figure 5: Future rendition of the prototype.  It will include a 
touch screen display, connections for oxygen flow, pressure 
sensing and an oxygen flow control knob.  The system will be 
powered by a rechargeable 7.2 volt 2200 mAh Li-ion battery.  
Computing will be provided by an AtMEGA 2560 
microcontroller.  
   
outcomes and help prevent injuries caused 
by hypoventilation. 
Aim 2: Simulation testing:  
We will place a nasal cannula on a 
mannequin head as shown in Figure 6.  
Using anatomically correct nasal/oral 
cavities, designed to demonstrated varying 
sizes and shapes of human anatomy, we 
will simulate the air flow and pressure 
measurements.  The 900C ventilator 
(Siemens Elema, Solna Sweden) will 
directly drive one chamber of the two 
chamber mechanical lung (Vent AID TTL; 
Michigan Instruments, Grand Rapids MI). A 
rigid metal strap will physically connect the 
two separate chambers of the mechanical 
lung.  When the ventilator delivers a tidal 
volume to the first chamber, the second 
chamber will rise, drawing in a tidal volume 
through the trachea of the mannequin, thus 
simulating a spontaneously breathing 
patient.  The lung compliance will be set to 
50 ml/cm H2O and with an airway resistance 
of 8.2 cm H2O/(L*s).  The spontaneously 
driven lung will provide the respiratory 
measurements through a 7.0 mm 
endotracheal tube (Sheridan Oral *Nasal, 
Teleflex Medical, PA) to the mannequin.  
The ventilator will provide tidal volumes of 
50, 100, 150, 300 and 500 mL and a 
respiratory rate of 1, 2, 4, 8, and 12 b/min.  
The accuracy by which the prototype 
delivers oxygen will be measured using a 
	  
Figure 6: Visual representation of the system that will be used in both simulation testing and clinical trials.  Includes a 
ventilator, two-chambered mechanical lung, mannequin, endotracheal tube, our pressure apnea monitor and 
supplemental oxygen.  The flow meter will control delivery of oxygen to the patient.  The pressure transducer 
measures nasal pressure through the nasal cannula.  Pneuflo resistors vary the ratio of nasal to oral breathing. 
gas flow analyzer (VT Plus, Fluke 
Biomedical, Everett, WA).  Furthermore, we 
will use one of three Pneuflo resistors 
(Michigan Instruments, Grand Rapids, MI) in 
the mouth of the mannequin to partially 
occlude the oral/nasal breathing to simulate 
one of three levels (3.3 mm, 5.6 mm, and 
7.7 mm).  Additionally, we will test total 
airway obstruction by closing the oral 
section completely.  During these 
simulations we will change the position of 
the cannula, moving the nasal prongs in and 
out of the nares.  Also we will test the 
outcomes when one nasal prong is in the 
nose and the other is outside of the nose.   
All outcomes will be analyzed and the 
device’s performance will be determined by 
classifying each breath as one of the 
following: True Positive (TP), if a breath 
delivered by the ventilator is detected 
correctly by the prototype; False Negative 
(FN), if a true breath is not detected; False 
Positive (FP), if a breath is detected when 
the ventilator does not deliver a breath; True 
Negative (TN), if no breath is delivered and 
the prototype detects no breath.  Sensitivity 
(TP/(TP+FN)) and specificity (TN/TN+FP)) 
will be calculated as the detection threshold 
for each alarm is adjusted.  This is done to 
find the optimum thresholds to provide 
accurate and reliable sensitivity and 
specificity.  It is anticipated that our device 
will have sensitivity of 98% and specificity of 
96%. 
Aim 3: Human trial in volunteers: 
In order to measure the apnea monitor’s 
performance in a clinical setting we will 
recruit 40 volunteers from patients receiving 
procedures in the Gastrointestinal (GI) Lab 
of the University of Utah Hospital.  Each 
patient will give prior consent to receiving a 
colonscopy procedure using the approved 
form provided by the University of Utah’s 
Institutional Review Board.  We chose to 
use the GI lab because Qadeer et al. 
reported that hypoxia occurs in 44-70% of 
all GI procedures [20].  With this being the 
case we anticipate to observe 
approximately 20 event of apnea. 
In addition to our prototype, we will be using 
an end tidal CO2 (EtCO2) divided sampling 
cannula with simultaneous oxygen delivery 
(Salter Labs, Arvin, CA) that will be placed 
on the patient.  During the procedure we will 
sample and record the SpO2 (NM3, Philips 
Medical), tidal volume and respiratory rate 
via respiratory inductance plethysmography 
chest bands (Q-RIP, Braebon, Ogdensburg, 
NY) and via a disposable thermister system 
(Model 517, Braebon, Ocgensburg, NY).  
This reference data will be reviewed and 
analyzed; respiratory rates and tidal 
volumes will be calculated.  Once the 
reference data is measured and annotated, 
detection of inadequate tidal volume and 
low respiratory rates, as measured by our 
prototype device, will be compared with the 
annotated reference data.  Sensitivity and 
specificity will be calculated for the detection 
of cannula displacement, inadequate tidal 
volume and respiratory rates, as described 
in Aim 2.  Once again it is anticipated that 
our pressure signal apnea monitor will have 
sensitivity of 98% and specificity of 96%. 
Conclusion: 
The use of a pressure signal apnea monitor 
has the potential to not only improve patient 
outcomes but to decrease overall health 
care costs.  The device uses fundamental 
principles that have been previously proven 
accurate and reliable.   
Future work will incorporate optimization of 
all software algorithms and hardware 
performances and durability.  Additionally, 
after all simulation testing and clinical data 
has been analyzed and reviewed the device 
will move from a laboratory prototype to a 
fully specified device for manufacturing.     
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